Clinical Trial Update: Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating monoclonal antibody therapy and vaccine therapy in patients with resected stage III or stage IV melanoma; results posted after c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Melanoma
• Melanoma

Drugs mentioned

• Monoclonal antibody therapy
• Vaccine therapy

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Intraocular Melanoma, Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2022-04-14